Northwestern Mutual Wealth Management
TAK icon

Northwestern Mutual Wealth Management’s Takeda Pharmaceutical TAK Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.7K Buy
1,227
+202
+20% +$3.34K ﹤0.01% 2880
2026
Q1 		$19K Sell
1,025
-2,201
-68% -$38.6K ﹤0.01% 2825
2025
Q4 		$50.3K Sell
3,226
-161
-5% -$2.3K ﹤0.01% 2397
2025
Q3 		$49.6K Sell
3,387
-199
-6% -$2.96K ﹤0.01% 2322
2025
Q2 		$55.4K Buy
3,586
+1,292
+56% +$19.1K ﹤0.01% 2218
2025
Q1 		$34.1K Sell
2,294
-595
-21% -$8.34K ﹤0.01% 2309
2024
Q4 		$38.3K Buy
2,889
+201
+7% +$2.76K ﹤0.01% 2274
2024
Q3 		$38.2K Sell
2,688
-2,108
-44% -$29.9K ﹤0.01% 2257
2024
Q2 		$62.1K Sell
4,796
-1,735
-27% -$23K ﹤0.01% 2006
2024
Q1 		$90.7K Buy
6,531
+4,187
+179% +$60.9K ﹤0.01% 1844
2023
Q4 		$33.4K Sell
2,344
-1,239
-35% -$17.6K ﹤0.01% 2210
2023
Q3 		$55.4K Sell
3,583
-2,919
-45% -$45.2K ﹤0.01% 1930
2023
Q2 		$102K Buy
6,502
+3,059
+89% +$50.1K ﹤0.01% 1707
2023
Q1 		$56.7K Buy
3,443
+467
+16% +$7.44K ﹤0.01% 1894
2022
Q4 		$46.4K Buy
2,976
+663
+29% +$9.26K ﹤0.01% 1942
2022
Q3 		$30K Sell
2,313
-125
-5% -$1.74K ﹤0.01% 2070
2022
Q2 		$34K Sell
2,438
-292
-11% -$4.17K ﹤0.01% 2043
2022
Q1 		$39K Buy
2,730
+1,871
+218% +$27.5K ﹤0.01% 2056
2021
Q4 		$12K Sell
859
-4,958
-85% -$69.5K ﹤0.01% 2509
2021
Q3 		$95K Buy
5,817
+4,970
+587% +$83.4K ﹤0.01% 1658
2021
Q2 		$14K Sell
847
-1,989
-70% -$33.9K ﹤0.01% 2330
2021
Q1 		$52K Buy
2,836
+2,359
+495% +$42.4K ﹤0.01% 1730
2020
Q4 		$9K Sell
477
-869
-65% -$15.2K ﹤0.01% 2231
2020
Q3 		$24K Buy
1,346
+904
+205% +$16.5K ﹤0.01% 1746
2020
Q2 		$8K Sell
442
-1,405
-76% -$25.2K ﹤0.01% 1976
2020
Q1 		$28K Buy
1,847
+1,213
+191% +$22K ﹤0.01% 1588
2019
Q4 		$13K Sell
634
-373
-37% -$7.14K ﹤0.01% 1868
2019
Q3 		$17K Sell
1,007
-4,942
-83% -$85.5K ﹤0.01% 1772
2019
Q2 		$105K Sell
5,949
-38,561
-87% -$702K ﹤0.01% 1097
2019
Q1 		$907K Buy
+44,510
New +$896K ﹤0.01% 473

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Northwestern Mutual Wealth Management's TAK Position: Q2 2026 in Review

Northwestern Mutual Wealth Management increased its Takeda Pharmaceutical (TAK) stake by 20% in Q2 2026, buying an estimated $3.34K and bringing the position to 1,227 shares worth $19.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2880.

Northwestern Mutual Wealth Management first reported a position in TAK in Q1 2019 and has held it in 30 quarters since. The position peaked at $907K in Q1 2019. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Northwestern Mutual Wealth Management held 1,227 shares of Takeda Pharmaceutical worth $19.7K as of Q2 2026.
  • Northwestern Mutual Wealth Management bought 202 Takeda Pharmaceutical shares in Q2 2026, an estimated $3.34K.
  • Takeda Pharmaceutical made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #2880 holding.
  • Northwestern Mutual Wealth Management first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 30 quarters since.
  • Northwestern Mutual Wealth Management's Takeda Pharmaceutical position peaked at $907K in Q1 2019.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.